Assurgen Pharma Profile
Key Indicators
- Authorised Capital ₹ 80.00 Cr
- Paid Up Capital ₹ 75.46 Cr
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 23.50 Cr
- Satisfied Charges ₹ 23.29 Cr
- Revenue Growth 2.92%
- Profit Growth 1.42%
- Ebitda 10.03%
- Net Worth 643.98%
- Total Assets 7.34%
About Assurgen Pharma
Assurgen Pharma Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 October 2013 and has a history of 11 years and four months. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 80.00 Cr and a paid-up capital of Rs 75.46 Cr.
The company currently has active open charges totaling ₹23.50 Cr. The company has closed loans amounting to ₹23.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Assurgen Pharma Private Limited India is Ishak Mohammed as COMPANY SECRETARY. Ravi Potluri, Dr Stark, Nagendra Kukalakunta, and Three other members serve as directors at the Company.
Company Details
-
Location
Visakhapatnam, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232AP2013PTC090442
-
Company No.
090442
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Oct 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
What products or services does Assurgen Pharma Private Limited offer?
Assurgen Pharma Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, API (Active Pharmaceutical Ingredients), Blood System and Cardiovascular API.
Who are the key members and board of directors at Assurgen Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagendra Kukalakunta
|
Managing Director | 10-Oct-2013 | Current |
| Ishak Mohammed | Company Secretary | 17-Mar-2022 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Srinivasa Vayetla
|
Director | 30-Nov-2017 | Current |
|
Ravi Potluri
|
Director | 20-Dec-2016 | Current |
Dr Stark
|
Director | 16-Aug-2019 | Current |
|
Naveen Parupalli
|
Director | 10-Oct-2013 | Current |
Paidi Rao
|
Director | 15-Nov-2014 | Current |
Financial Performance of Assurgen Pharma.
Assurgen Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.92% increase. The company also saw a slight improvement in profitability, with a 1.42% increase in profit. The company's net worth Soared by an impressive increase of 643.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Assurgen Pharma?
In 2023, Assurgen Pharma had a promoter holding of 90.91% and a public holding of 9.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aet Laboratories Private LimitedDr Stark is a mutual person
Charges (Loans)
₹23.50 Cr
₹23.29 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 23.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2021 | Hdfc Bank Limited | ₹23.50 Cr | Open |
| 28 Jan 2019 | Others | ₹8.00 M | Satisfied |
| 05 Aug 2017 | Others | ₹4.00 Cr | Satisfied |
| 27 Mar 2017 | Others | ₹2.49 Cr | Satisfied |
| 24 Nov 2015 | Andhra Pradesh State Financial Corporation. | ₹16.00 Cr | Satisfied |
How Many Employees Work at Assurgen Pharma?
Assurgen Pharma has a workforce of 135 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Assurgen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assurgen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
